FDA advisers unanimously back over-the-counter birth control pill
As a meeting of outside experts nears, the FDA wants to know whether people will use Perrigo's OTC birth control pill Opill safely in the real world.
The delay comes as the FDA needs more time to review additional information requested from Perrigo.
July 11 (Reuters) - Perrigo Company (PRGO.N) said on Monday its unit HRA Pharma has asked the U.S. Food and Drug Administration (FDA) to approve a daily birth control pill for over-the-counter (OTC) sale, the first such request for this type of contraception. The application from the HRA comes on the back of the U.S. Supreme Court's decision in June to overturn the 1973 Roe v. Wade case that legalized abortion nationwide.
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that on April 29, 2022 it completed the...
HRA Pharma has launched its emergency contraceptive brand on social media, setting up new UK-focused channels on for ellaOne on Facebook and Twitter.
For HRA Pharma Golin will be working to raise awareness of the French company's emergency contraceptive pill ellaOne (ulipristal acetate) in the UK, targeting both pharmacists and women of childbearing age.
HRA Pharma`s Generic Ketoconazole HRA (Ketoconazole 200 mg) Approved in Europe for Cushing`s Syndrome